LEXEO Therapeutics is Biotechnology in United States that focus on disease areas business. Founded in 2018. They cover business area such as developer, hereditary and acquire disease, high unmet need, Adeno-associate virus, (AAV, gene, vulnerable organ, oxidant stress, proteolytic enzyme, inflammatory cell, patient.
2018
( 6 years old in 2024 )
Disease Areas
-
430 East 29th Street
14th Floor
New York, NY 10026
United States
Private
developerhereditary and acquire diseasehigh unmet needAdeno-associate virus(AAVgenevulnerable organoxidant stressproteolytic enzymeinflammatory cellpatient
* We use standard office opening hours in near LEXEO Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
LEXEO Therapeutics is Biotechnology business from United States that founded in 2018 (6 years old in 2024), LEXEO Therapeutics business is focusing on Disease Areas.
LEXEO Therapeutics headquarter office and corporate office address is located in 430 East 29th Street 14th Floor New York, NY 10026 United States.
LEXEO Therapeutics was founded in United States.
In 2024, LEXEO Therapeutics is currently focus on disease areas sector.
Above is snippet of Google Trends for "disease areas" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with LEXEO Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
